Atlas Trials

RAS Mutation

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch RAS Mutation

RecordFirmDate
NAUTILUS: OKI-179 Plus Binimetinib in Patients with Advanced Solid Tumors in the RAS Pathway (Phase 1b) and NRAS-mutated Melanoma (Phase 2) (NCT05340621)OnKure, Inc.2022-05-11
Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors (NCT07121829)Day One Biopharmaceuticals, Inc.2022-05-02
Centralized Tumour Board and Secondary Intervention Rate in mCRC (NCT04852250)Ludwig-Maximilians - University of Munich2021-06-01
PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC (NCT06206096)Chinese PLA General Hospital2021-05-26
Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB (NCT04776655)Azienda USL Reggio Emilia - IRCCS2021-04-30
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies (NCT04678648)RasCal Therapeutics, Inc.2021-03-03
Sintilimab (IBI308) Combined With Bevacizumab + XELOX Regimen in Metastatic Colorectal Cancer (NCT04194359)Second Affiliated Hospital, Zhejiang University, School of Medicine2021-02-04
Hematological Anomalies in Children With Rasopathy (NCT04286360)Assistance Publique - Hôpitaux de Paris2020-11-11
RASopathy Biorepository (NCT04395495)Children's Hospital Medical Center, Cincinnati2017-06-27

Track RAS Mutation automatically

Every clearance here is in the API, with alerts when new ones post.